Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

(R)-H-DOA: new agent for osteoporosis extracted from plants

Sep. 24, 1999

Kyowa Hakko presents heterocyclic compounds for osteoporosis

Sep. 24, 1999

Antihyperglycemic effects of novel imidazoline derivative investigated

Sep. 23, 1999

Discovery Laboratories reaches first marketing agreement for osteoporosis drug

Sep. 23, 1999

CHF-3316 - a new isoflavone with characteristics of a SERM

Sep. 22, 1999

AHP pays milestone to Ligand for progesterone receptor antagonist

Sep. 22, 1999

Novel partial estrogen agonists developed at American Home Products

Sep. 22, 1999

Glaxo Wellcome's GW-9578 is the most potent PPARalpha agonist yet reported

Sep. 21, 1999

Japanese launch of nateglinide announced

Sep. 21, 1999

Positive preclinical results reported for Hemopure

Sep. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...